Security key
834203309
Soleno Therapeutics, Inc. - Common Stock (SLNO)
CUSIP: 834203309
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 31,409,972
- Total 13F value
- $1,264,282,488
- Share change
- +9,808,777
- Put/Call ratio
- 160%
- SEC-reported price per share
- $40.25
- Number of holders
- 76
- Value change
- +$428,860,586
- Number of buys
- 55
- Number of sells
- 22
- Shares outstanding
- 51,293,400
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
76
Top holders
10
SLNO full security history
Ownership snapshot
Full 13F holder table
SOLENO THERAPEUTICS INC SEC filings
SOLENO THERAPEUTICS INC company facts
Broader feeds
Ownership snapshot
Top reported holders of SLNO - Soleno Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Abingworth LLP
Disclosed value leader
Abingworth LLP
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $657,560,041
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Abingworth LLP has the largest disclosed position value at $657.56M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Abingworth LLP's linked filing trail.
Disclosed position value
Top 5
Abingworth LLP
$657.56M
PERCEPTIVE ADVISORS LLC
$112.18M
Carlyle Group Inc.
$67.43M
Jack W. Schuler
$1.34M
Vivo Capital, LLC
$94.52M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Abingworth LLP |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$657,560,041
25,774,464 shares
mixed-class rows
|
— | 21 Dec 2018 |
| PERCEPTIVE ADVISORS LLC |
3/4/5
13F
10%+ Owner · Company
|
—
mixed-class rows
|
$112,175,587
3,324,542 shares
mixed-class rows
|
— | 26 Sep 2023 |
| Carlyle Group Inc. |
13F
3/4/5
Company · 10%+ Owner
|
—
mixed-class rows
|
$67,430,723
2,293,562 shares
|
— | 30 Sep 2023 |
| Jack W. Schuler |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,335,180
36,595 shares
|
— | 09 Dec 2022 |
| Vivo Capital, LLC |
13F
Company
|
—
denominator unverified
|
$94,523,274
3,203,093 shares
|
— | 30 Sep 2023 |
| Janus Henderson Group Ltd. |
13F
Company
|
—
denominator unverified
|
$64,999,808
2,204,053 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
76
Shares
31,409,972
Rows available
76
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
54
Q4 2023 holders
76
Holder diff
22
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|